Asta Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of mass spectrometry equipment. The Company is mainly engaged in the manufacture and sale of matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) based mass spectrometers and related consumables, which are mainly applied in display, secondary battery, and semiconductor industries.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Korea S.E. Other stock markets 24/03/2026			5-day change	1st Jan Change
6,070.00 ^KRW	-2.57%		-.--%	-26.60%

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI

Market Cap	80.69B 119,988B 70.52B 65.07B 59.98B 113B 7,771B 116B 778B 306B 3,806B 303B 296B 13,101B	P/E 2021	-15.4x	P/E 2022	-17.8x
Enterprise Value	77.96B 115,934B 68.13B 62.87B 57.95B 109B 7,508B 112B 751B 296B 3,677B 293B 286B 12,659B	EV / Sales 2021	21.1x	EV / Sales 2022	14.4x
Free-Float	54.42%	Yield 2021 *	-	Yield 2022	-

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI
02-24	ASTA Corporation announced that it has received KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-10	ASTA Corporation announced that it expects to receive KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-10	SD Biosensor, Inc. entered into a Share Purchase Agreement to acquire 27.19% stake in ASTA Corporation from Cho Eung-jun and Kim Yang-sun for KRW 32.8 billion.	CI
12-29	ASTA Corporation announced that it has received KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
12-19	ASTA Corporation announced that it expects to receive KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
30/09/25	ASTA Corporation announced that it has received KRW 2.0000304 billion in funding	CI
11/08/25	ASTA Corporation announced that it expects to receive KRW 2.0000304 billion in funding	CI
30/06/25	ASTA Corporation announced that it has received KRW 2.700036 billion in funding from KB Securities Co., Ltd.	CI
20/06/25	ASTA Corporation announced that it expects to receive KRW 2.700036 billion in funding	CI
10/03/25	ASTA Corporation announced that it has received KRW 3 billion in funding	CI
06/03/25	ASTA Corporation announced that it expects to receive KRW 3 billion in funding	CI

1 day	-2.57%
6 months	-24.31%
Current year	-26.60%

ASTA Corporation Stock

Stocks

A246720

KR7246720007

Medical Equipment, Supplies & Distribution

Valuation: ASTA Corporation

Chart: ASTA Corporation

Latest news : ASTA Corporation

Quotes and Performance

Course Extremes

Managers and Directors: ASTA Corporation

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Current year	5,900	11,080
1 year	5,530	11,080
3 years	3,810	12,400
5 years	3,060	13,050
10 years	2,780	29,500

Manager	Title	Age	Since
Eung-Jun Cho CEO	Chief Executive Officer	72	01/01/2006
Jong-Wan Park DFI	Director of Finance/CFO	56	01/11/2018
Yang-Sun Kim CEO	Chief Executive Officer	68	01/01/2006

Director	Title	Age	Since
Eung-Soo Cho BRD	Director/Board Member	70	01/12/2015
Eung-Jun Cho CHM	Chairman	72	-
Sang-Il Kim BRD	Director/Board Member	51	30/09/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASTA CORPORATION	-2.57%	-.--%	+5.57%	-41.07%	66.87M
ABBOTT LABORATORIES	+1.87%	+7.19%	-18.59%	-5.86%	175B
MEDTRONIC PLC	-0.43%	-0.80%	-7.15%	-3.93%	106B
CENCORA, INC.	-0.03%	+1.47%	+5.13%	+60.04%	59.91B
HOYA CORPORATION	+0.66%	+0.96%	+37.64%	+54.65%	51.95B
BECTON, DICKINSON AND COMPANY	-1.10%	+4.10%	-11.56%	-38.29%	43.58B
MEDLINE INC.	-3.21%	-3.05%	-	-	33.65B
DEXCOM, INC.	-1.71%	+2.25%	-8.63%	-44.43%	29.58B
WEST PHARMACEUTICAL SERVICES, INC.	-1.16%	+1.28%	+69.87%	-6.85%	25.31B
STERIS PLC	-1.49%	+0.85%	-3.43%	-4.01%	21.23B
Average	-0.92%	+0.30%	+7.65%	-3.31%	54.71B
Weighted average by Cap.	+0.09%	+2.75%	-1.60%	+3.40%

	2021	2022
Net sales	2.56B 3,813B 2.24B 2.07B 1.91B 3.59B 247B 3.67B 24.71B 9.72B 121B 9.63B 9.42B 416B	3.35B 4,975B 2.92B 2.7B 2.49B 4.69B 322B 4.79B 32.25B 12.68B 158B 12.56B 12.29B 543B
Net income	-3.53B -5,252B -3.09B -2.85B -2.63B -4.95B -340B -5.06B -34.04B -13.39B -167B -13.26B -12.97B -573B	-2.8B -4,163B -2.45B -2.26B -2.08B -3.92B -270B -4.01B -26.98B -10.61B -132B -10.51B -10.28B -455B
Net Debt	-5.5B -8,179B -4.81B -4.44B -4.09B -7.71B -530B -7.88B -53.02B -20.85B -259B -20.66B -20.2B -893B	-2.73B -4,054B -2.38B -2.2B -2.03B -3.82B -263B -3.9B -26.28B -10.34B -129B -10.24B -10.01B -443B